These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30019627)

  • 1. Treatment with exenatide in acute ischemic stroke trial protocol: A prospective, randomized, open label, blinded end-point study of exenatide vs. standard care in post stroke hyperglycemia.
    Muller C; Cheung NW; Dewey H; Churilov L; Middleton S; Thijs V; Ekinci EI; Levi C; Lindley R; Donnan G; Parsons M; Bladin C
    Int J Stroke; 2018 Oct; 13(8):857-862. PubMed ID: 30019627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study.
    McGrath RT; Hocking SL; Priglinger M; Day S; Herkes GK; Krause M; Fulcher GR
    BMJ Open; 2016 Feb; 6(2):e008203. PubMed ID: 26911582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
    Johnston KC; Bruno A; Pauls Q; Hall CE; Barrett KM; Barsan W; Fansler A; Van de Bruinhorst K; Janis S; Durkalski-Mauldin VL;
    JAMA; 2019 Jul; 322(4):326-335. PubMed ID: 31334795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital exenatide in hyperglycemic stroke-A randomized trial.
    Larsson M; Castrén M; Lindström V; von Euler M; Patrone C; Wahlgren N; Nathanson D
    Acta Neurol Scand; 2019 Dec; 140(6):443-448. PubMed ID: 31518433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke.
    Bruno A; Durkalski VL; Hall CE; Juneja R; Barsan WG; Janis S; Meurer WJ; Fansler A; Johnston KC;
    Int J Stroke; 2014 Feb; 9(2):246-51. PubMed ID: 23506245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial.
    Xu S; Liu X; Ming J; Ji Q
    Trials; 2016 Mar; 17():160. PubMed ID: 27009108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia.
    Staszewski J; Brodacki B; Kotowicz J; Stepien A
    J Stroke Cerebrovasc Dis; 2011; 20(2):150-4. PubMed ID: 20621520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluate the Efficacy and Safety of Human Urinary Kallidinogenase (RESK): Protocol for an Open-Label, Single-Arm, Multicenter Phase IV Trial for the Treatment of Acute Ischemic Stroke in Chinese Patients.
    Ni J; Qu J; Yao M; Zhang Z; Zhong X; Cui L;
    Transl Stroke Res; 2017 Aug; 8(4):341-346. PubMed ID: 28265861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia predicts unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis among a Chinese population: A prospective cohort study.
    Lin SF; Chao AC; Hu HH; Lin RT; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Sun MH; Wei CY; Lin YT; Lee JT; Bai CH;
    J Neurol Sci; 2018 May; 388():195-202. PubMed ID: 29627022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke.
    Putaala J; Sairanen T; Meretoja A; Lindsberg PJ; Tiainen M; Liebkind R; Strbian D; Atula S; Artto V; Rantanen K; Silvonen P; Piironen K; Curtze S; Häppölä O; Mustanoja S; Pitkäniemi J; Salonen O; Silvennoinen H; Soinne L; Kuisma M; Tatlisumak T; Kaste M
    Cerebrovasc Dis; 2011; 31(1):83-92. PubMed ID: 21079397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial.
    Wiberg S; Hassager C; Schmidt H; Thomsen JH; Frydland M; Lindholm MG; Høfsten DE; Engstrøm T; Køber L; Møller JE; Kjaergaard J
    Circulation; 2016 Dec; 134(25):2115-2124. PubMed ID: 27838646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Conscious Sedation vs General Anesthesia on Early Neurological Improvement Among Patients With Ischemic Stroke Undergoing Endovascular Thrombectomy: A Randomized Clinical Trial.
    Schönenberger S; Uhlmann L; Hacke W; Schieber S; Mundiyanapurath S; Purrucker JC; Nagel S; Klose C; Pfaff J; Bendszus M; Ringleb PA; Kieser M; Möhlenbruch MA; Bösel J
    JAMA; 2016 Nov; 316(19):1986-1996. PubMed ID: 27785516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombectomy in patients ineligible for iv tPA (THRILL).
    Bendszus M; Thomalla G; Knauth M; Hacke W; Bonekamp S; Fiehler J
    Int J Stroke; 2015 Aug; 10(6):950-5. PubMed ID: 26044962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Moderate control of hyperglycemia after acute stroke in the intensive care unit].
    Wainsztein NA; Pujol Lereis VA; Capparelli FJ; Hlavnika A; Díaz MF; Leiguarda RE; Ameriso SF
    Medicina (B Aires); 2014; 74(1):37-41. PubMed ID: 24561838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial.
    Lai X; Cao K; Kong L; Liu Q; Gao Y;
    Trials; 2017 Oct; 18(1):479. PubMed ID: 29037226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemic control in acute ischemic stroke patients undergoing endovascular treatment: post hoc analysis of the Stroke Hyperglycemia Insulin Network Effort trial.
    Bains NK; Huang W; French BR; Siddiq F; Gomez CR; Qureshi AI
    J Neurointerv Surg; 2023 Apr; 15(4):370-374. PubMed ID: 35414602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial.
    Bruno A; Kent TA; Coull BM; Shankar RR; Saha C; Becker KJ; Kissela BM; Williams LS
    Stroke; 2008 Feb; 39(2):384-9. PubMed ID: 18096840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.